Human ischemia modified albumin can be a predictive biomarker for the detection of peripheral ischemia duration

HealthMED

Volumn 6, Issue 10, 2012, Pages 3478-3481

  Yavuz, Celal ^a   Caliskan, Ahmet ^a   Yazici, Suleyman ^a   Karahan, Oguz ^a   Guclu, Orkut ^a   Demirtas, Sinan ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Biomarker; Human ischemia modified albumin; Peripheral ischemia; Treatment timing

Indexed keywords

BIOLOGICAL MARKER; ISCHEMIA MODIFIED ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMORAL ARTERY; INCISION; MALE; NONHUMAN; PERIPHERAL ISCHEMIA; RAT;

EID: 84871226520     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 2001; 94(6): 1133-8.
2. Tarantini G, Cacciavillani L, Corbetti F, Ramondo A, Marra MP, Bacchiega E. et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol. 2005: 46(7): 1229-35.
3. Al-Mubarak HA, Alamri TM, Aljabab SA, Atteya M, Quan A, Teoh H. et al. Effects on duration of post-operative ischemia and patterns of blood flow recovery in different conditions of mouse hind limb ischemia. Vasc Cell. 2011; 3(1): 14.
4. Beard JD. Chronic lower limb ischemia. West J Med. 2000; 173(1): 60-3.
5. Smadja DM, Duong-van-Huyen JP, Dal Cortivo L, Blanchard A, Bruneval P, Emmerich J. et al. Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia. Cytotherapy. 2012; 14(2): 232-9.
6. Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res. 2012; 110(4): 624-37.
7. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med. 2000; 19: 311-315.
8. Dominguez-Rodriguez A, Abreu-Gonzalez P. Ischemia-modified albumin: we are ready for use in the emergency room? Int J Cardiol. 2011; 151(2): 247.
9. Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes-review and clinical implications. Clin Chem Lab Med. 2011; 49(2): 177-84.
10. Lippi G, Montagnana M. Ischemia-modified albumin in ischemic disorders. Ann Thorac Cardiovasc Surg. 2009; 15: 137.
11. Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D. et al. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem. 2004; 50(9): 1656-60.
12. Dikensoy O, Celik N, Kul S, Gogebakan B, Bayram H, Light RW. Ischemia modified albumin in the differential diagnosis of pleural effusions. Respir Med. 2011; 105(11): 1712-7.
13. Jordan RW, Marks A, Higman D. The cost of major lower limb amputation: a 12-year experience. Prosthet Orthot Int. 2012 DOI: 10.1177/0309364612441489.
14. Lee WS, Lee KJ, Ryu WS. Acute embolic occlusion of the left common iliac artery treated with intra-arterial thrombolysis and percutaneous thrombectomy. Korean J Intern Med. 2009; 24(2): 153-5.
15. Haimovici H. Muscular, renal, and metabolic complications of acute arterial occlusions: myonephropathic-metabolic syndrome. Surgery. 1979; 85(4): 461-8.
16. Brahimi-Horn MC, Ben-Hail D, Ilie M, Gounon P, Rouleau M, Hofman V. et al. Expression of a Truncated Active Form of VDAC1 in Lung Cancer Associates with Hypoxic Cell Survival and Correlates with Progression to Chemotherapy Resistance. Cancer Res. 2012; 72(8): 2140-2150.
17. Sadayappan S. Cardiac myosin binding protein-C: a potential early-stage, cardiac-specific biomarker of ischemia-reperfusion injury. Biomark Med. 2012; 6(1): 69-72.
18. Gunduz A, Mentese A, Turedi S, Karahan SC, Mentese U, Eroglu O. et al. Serum ischaemia-modified albumin increases in critical lower limb ischaemia. Emerg Med J. 2008; 25(6): 351-3.
19. Hacker M, Hoyer HX, la Fougère C, Akcakoyunlu E, Schuhmann C, Förster S. et al. Effects of peripheral vascular intervention on ischemia-modified albumin. Coron Artery Dis. 2007; 18(5): 375-9.